Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company focusing on adeno-associated ... Taysha is in advanced discussions with the FDA regarding trial design and endpoints, aiming for ...
The panel featured industry leaders from the pharmaceutical and biotech sectors, who discussed these challenges and provided ...
TORK US on MSN18h
This is how Audi was born: the origin of its iconic four ringsThis is the origin of the Audi logo, a symbol full of globalization, a design available to any mortal, easy to reproduce by ...
Biotheus’ antibody drug targets PD-L1 and VEGF, a design that’s high on drugmakers’ radars after the success of Summit ...
CARLSBAD, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, ...
Both Big Pharma Sanofi and AI-focused biotech Formation Bio plan on using Muse in upcoming clinical trials, with an initial ...
LISBON, Portugal--(BUSINESS WIRE)--Picsart, with over 100 million monthly users, has launched an AI-powered Logo Maker tailored to small businesses, solopreneurs, and side hustlers. Designed for ...
The global artificial intelligence (AI) in drug discovery market is projected to reach USD 6.89 billion by 2029 from USD 1.86 ...
The largest ever clinical trial of T cell therapy for solid tumors has ended, heralding a new era for precision T cell therapy.
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the ...
The FDA has also aligned on Innocan's non-clinical development plan and Phase I clinical study design for the LPT-CBD's Investigational ... Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback